Hoth Therapeutics 迎来欧盟关键监管节点,推动HT-001肿瘤试验在多国启动临床中心

美股速递
Jan 15

Hoth Therapeutics近日迎来其在欧盟监管流程中的关键转折点,为公司核心肿瘤疗法HT-001的临床试验铺平道路。这一进展将直接推动试验方案在多个欧洲国家启动临床研究中心,加速全球研发布局。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10